DrugDashboards

Levophed

Norepinephrine Bitartrate · NOREPINEPHRINE BITARTRATE 1 mg/mL · Injection, Solution, Concentrate · Intravenous · Hospira, Inc.

NDC 00409-3375-04 · 10 VIAL, SINGLE-DOSE in 1 CARTON / 4 mL in 1 VIAL, SINGLE-DOSE · NDA · View full market →

The short version

12 companies supply this market — deep enough that no single failure threatens the supply.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$224.75
Reported to Texas DSHS · 2026 annual filing · Pfizer Inc.

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$676
14 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

  • Hospira, Inc.United States
    analysis · label · manufacture · pack

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
NDA007513
TE code
AP
Approval date
Jan 1, 1982
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

  • Class II · TerminatedAug 22, 2017
    Pfizer Inc. — Lack of sterility assurance: resulting from use of a damaged sterilizing filter for nitrogen used in the manufacturing process.
  • Class II · TerminatedMay 18, 2017
    Hospira Inc., A Pfizer Company — GMP Deviation; A foreign stopper was observed during packaging of a lot of product.

Manufacturers of Norepinephrine Bitartrate (Injection, Solution, Concentrate)

LabelerStrengthFirst seenLast seen
Hospira, Inc.NOREPINEPHRINE BITARTRATE 1 mg/mLJul 15, 2026Sep 3, 2026
Mylan Institutional LLCNOREPINEPHRINE BITARTRATE 1 mg/mLJul 15, 2026Sep 3, 2026
Amneal Pharmaceuticals LLCNOREPINEPHRINE BITARTRATE 1 mg/mLJul 15, 2026Sep 2, 2026
Anthea Pharma Private LimitedNOREPINEPHRINE BITARTRATE 1 mg/mLJul 15, 2026Sep 2, 2026
Biocon Pharma Inc.NOREPINEPHRINE BITARTRATE 1 mg/mLJul 15, 2026Sep 2, 2026
Breckenridge Pharmaceutical, Inc.NOREPINEPHRINE BITARTRATE 1 mg/mLJul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.NOREPINEPHRINE BITARTRATE 1 mg/mLJul 15, 2026Sep 2, 2026
Civica, Inc.NOREPINEPHRINE BITARTRATE 1 mg/mLJul 15, 2026Sep 2, 2026
Meitheal Pharmaceuticals Inc.NOREPINEPHRINE BITARTRATE 1 mg/mLJul 15, 2026Sep 2, 2026
Novadoz Pharmaceuticals LLCNOREPINEPHRINE BITARTRATE 1 mg/mLJul 15, 2026Sep 2, 2026
Sandoz IncNOREPINEPHRINE BITARTRATE 1 mg/mLJul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.NOREPINEPHRINE BITARTRATE 1 mg/mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Levophed — NDC 00409-3375-04," retrieved September 3, 2026, https://drugdashboards.com/drug/00409337504.

Free to cite with attribution — see how the data is put together.